Previous research has found that a Mediterranean-style diet can combat health problems linked with obesity. A Mediterranean-style diet contains higher amounts of fruits and vegetables. High amounts of ...

SAN AN­TO­NIO — Zealand Phar­ma, hop­ing to cre­ate the next “foun­da­tion­al” ther­a­py for obe­si­ty, de­tailed more Phase 1 da­ta on its amylin ana­log that was the … ...

AstraZeneca on Monday touted the competitive potential of its weight management pipeline at The Obesity Society’s ObesityWeek 2024 meeting in San Antonio, Texas, revealing early data for its oral ...

CEO Pascal Soriot acknowledged after the Eccogene deal that AstraZeneca was "a few years behind" Novo Nordisk and Eli Lilly who were first to market with highly effective obesity drugs.

Jean Adams, Professor of Dietary Public Health at the University of Cambridge’s MRC Epidemiology Unit and Martin White, Professor of Population Health Research at the University of Cambridge’s MRC ...

Several risk factors for obesity, such as genetics, metabolism, and hormones, are outside your control. Depending on your circumstances, you may be able to reduce your risk of obesity by making ...

Anthocyanins, the organic colorants that provide fruits and vegetables with their bright shades, are lauded for their potential health advantages and antioxidant abilities. Consequently, those who ...

A person with Down syndrome may be more likely to develop obesity than someone without it. This is due to additional medical conditions and physiological factors, among other reasons. A person who ...

A blockbuster weight-loss drug sharply reduces pain from obesity-related arthritis in the knees and improves people’s ability to engage in activities such as walking. That’s according to a ...

Here's a look at the latest research and promising results: After trying to address diabetes and obesity, GLP-1 studies have focused on CV risks and events. The SELECT trial found semaglutide ...

GLP-1 receptor agonists are revolutionizing health care, moving beyond diabetes and obesity to treat cardiovascular, kidney, and possibly neurodegenerative diseases. As usage expands and costs drop, ...